2018 Thalamocortical Interactions Gordon Research Conference

项目摘要 戈登研究会议（GRC）关于“丘脑皮质的相互作用：发展，功能和 丘脑皮质网络功能障碍”将涉及大约150名不同专业知识的科学家， 讨论和辩论有关丘脑和皮质功能及其相互作用的新发现。的 会议将于2月18日至23日在意大利卢卡（巴尔加）文艺复兴时期的托斯卡纳伊尔乔科举行， 2018.会议将包括一系列20分钟的会谈，然后是10分钟的讨论时间， 在海报展示会上进行不那么正式的互动。该GRC将提供独特的功能组合， 包括：研究的广度;尖端的重点;来自各级和不同子系统的调查人员的混合， 领域和地区;亲密的大小和延长的讨论时间，允许密切和持续的互动。 该GRC的计划强调丘脑皮质相互作用的发展，功能和功能障碍， 并在此基础上探索它们在认知和神经元疾病状态中的作用。这个GRC代表了一种罕见的 对丘脑皮质相互作用感兴趣的神经科学家有机会交流新的结果，假设， 从细胞到系统，从认知到临床。这是特别及时的， 因为最近人们认识到丘脑在大脑中起着持续的作用， 在皮质功能中的重要作用，以及新描述的精神分裂症，癫痫， 和孤独症似乎至少有一部分是丘脑皮质的。因此，我们完全预计， 推进该领域，并可能为某些临床条件提供新的见解。

PROJECT SUMMARY The Gordon Research Conference (GRC) on “Thalamocortical Interactions: Development, Function & Dysfunction of Thalamocortical Networks” will involve roughly 150 scientists of diverse expertise assembled to discuss and debate new findings related to the functioning of thalamus and cortex and their interactions. The conference will take place at the Renaissance Tuscany Il Ciocco, Lucca (Barga), Italy, during February 18-23, 2018. The meeting will include a series of 20 minute talks followed by 10 minute discussion periods plus time each day for less formal interactions at poster sessions. This GRC will offer a unique combination of features, including: breadth of research; cutting-edge emphasis; mingling of investigators from all ranks and diverse sub- fields and locales; and intimate size and extended discussion time, allowing for close and sustained interactions. The program of this GRC emphasizes development, function and dysfunction of thalamocortical interactions, and builds on these to explore their roles in cognition and neuronal disease states. This GRC represents a rare opportunity for neuroscientists interested in thalamocortical interactions to exchange new results, hypotheses, and ideas at many levels, from cellular through systems to cognitive and clinical. This is especially timely, because this field has been expanding significantly with the recent appreciation that thalamus plays an ongoing and critical role in cortical functioning, and newly described deficits in such disorders as schizophrenia, epilepsy, and autism appear to have at least partly a thalamocortical locus. We thus fully anticipate this GRC to significantly advance the field and potentially offer new insights into certain clinical conditions.